Akoya Biosciences Inc (AKYA)
2.85
-0.05
(-1.72%)
USD |
NASDAQ |
May 17, 16:00
2.85
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences Accounts Payable (Quarterly): 10.75M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 10.75M |
December 31, 2023 | 11.78M |
September 30, 2023 | 11.89M |
June 30, 2023 | 11.73M |
March 31, 2023 | 8.683M |
December 31, 2022 | 10.63M |
September 30, 2022 | 8.172M |
Date | Value |
---|---|
June 30, 2022 | 13.37M |
March 31, 2022 | 11.52M |
December 31, 2021 | 9.435M |
September 30, 2021 | 4.071M |
June 30, 2021 | 4.898M |
March 31, 2021 | 5.776M |
December 31, 2020 | 5.074M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.071M
Minimum
Sep 2021
13.37M
Maximum
Jun 2022
9.127M
Average
10.03M
Median
Accounts Payable (Quarterly) Benchmarks
Azenta Inc | 37.32M |
Harvard Bioscience Inc | 6.044M |
Standard BioTools Inc | 13.14M |
Bionano Genomics Inc | 9.844M |
Singular Genomics Systems Inc | 2.012M |